• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆囊收缩素2受体在大鼠和人L细胞中的表达以及胃泌素处理对胰高血糖素样肽-1分泌的刺激作用。

Expression of cholecystokinin2-receptor in rat and human L cells and the stimulation of glucagon-like peptide-1 secretion by gastrin treatment.

作者信息

Cao Yang, Cao Xun, Liu Xiao-Min

机构信息

Department of Endocrinology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.

Department of Endocrinology, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.

出版信息

Acta Histochem. 2015 Mar;117(2):205-10. doi: 10.1016/j.acthis.2014.12.007. Epub 2015 Jan 15.

DOI:10.1016/j.acthis.2014.12.007
PMID:25601282
Abstract

Gastrin is a gastrointestinal hormone secreted by G cells. Hypergastrinemia can improve blood glucose and glycosylated hemoglobin levels. These positive effects are primarily due to the trophic effects of gastrin on β-cells. In recent years, many receptors that regulate secretion of glucagon-like peptide 1 (GLP-1) have been identified in enteroendocrine L cell lines. This led us to hypothesize that, in addition to the trophic effects of gastrin on β-cells, L cells also express cholecystokinin2-receptor (CCK2R), which may regulate GLP-1 secretion and have synergistic effects on glucose homeostasis. Our research provides a preliminary analysis of CCK2R expression and the stimulating effect of gastrin treatment on GLP-1 secretion in a human endocrine L cell line, using RT-PCR, Western blot, immunocytochemistry, and ELISA analyses. The expression of proglucagon and prohormone convertase 3, which regulate GLP-1 biosynthesis, were also analyzed by real-time PCR. Double immunofluorescence labeling was utilized to assess the intracellular localization of CCK2R and GLP-1 in L cells harvested from rat colon tissue. Our results showed that CCK2R was expressed in both the human L cell line and the rat L cells. We also showed that treatment with gastrin, a CCK2R agonist, stimulated the secretion of GLP-1, and that this effect was likely due to increased expression of proglucagon and PCSK1 (also known as prohormone convertase 3 (PC3 gene)). These results not only provide a basis for the role gastrin may play in intestinal L cells, and may also provide the basis for the development of a method of gastrin-mediated glycemic regulation.

摘要

胃泌素是一种由G细胞分泌的胃肠激素。高胃泌素血症可改善血糖和糖化血红蛋白水平。这些积极作用主要归因于胃泌素对β细胞的营养作用。近年来,在肠内分泌L细胞系中已鉴定出许多调节胰高血糖素样肽1(GLP-1)分泌的受体。这使我们推测,除了胃泌素对β细胞的营养作用外,L细胞还表达胆囊收缩素2受体(CCK2R),其可能调节GLP-1分泌并对葡萄糖稳态产生协同作用。我们的研究使用逆转录聚合酶链反应(RT-PCR)、蛋白质免疫印迹法、免疫细胞化学和酶联免疫吸附测定(ELISA)分析,对人内分泌L细胞系中CCK2R的表达以及胃泌素处理对GLP-1分泌的刺激作用进行了初步分析。还通过实时聚合酶链反应分析了调节GLP-1生物合成的胰高血糖素原和激素原转化酶3的表达。利用双重免疫荧光标记评估从大鼠结肠组织收获的L细胞中CCK2R和GLP-1的细胞内定位。我们的结果表明,CCK2R在人L细胞系和大鼠L细胞中均有表达。我们还表明,用CCK2R激动剂胃泌素处理可刺激GLP-1的分泌,并且这种作用可能是由于胰高血糖素原和PCSK1(也称为激素原转化酶3(PC3基因))表达增加所致。这些结果不仅为胃泌素在肠道L细胞中可能发挥的作用提供了依据,也可能为开发胃泌素介导的血糖调节方法提供依据。

相似文献

1
Expression of cholecystokinin2-receptor in rat and human L cells and the stimulation of glucagon-like peptide-1 secretion by gastrin treatment.胆囊收缩素2受体在大鼠和人L细胞中的表达以及胃泌素处理对胰高血糖素样肽-1分泌的刺激作用。
Acta Histochem. 2015 Mar;117(2):205-10. doi: 10.1016/j.acthis.2014.12.007. Epub 2015 Jan 15.
2
CCK-1 and CCK-2 receptor agonism do not stimulate GLP-1 and neurotensin secretion in the isolated perfused rat small intestine or GLP-1 and PYY secretion in the rat colon.胆囊收缩素-1 和胆囊收缩素-2 受体激动剂不能刺激离体灌注大鼠小肠中的 GLP-1 和神经降压素分泌,也不能刺激大鼠结肠中的 GLP-1 和 PYY 分泌。
Physiol Rep. 2020 Jan;8(2):e14352. doi: 10.14814/phy2.14352.
3
Chronic Exposure to TNFα Impairs Secretion of Glucagon-Like Peptide-1.长期暴露于肿瘤坏死因子α会损害胰高血糖素样肽-1的分泌。
Endocrinology. 2015 Nov;156(11):3950-60. doi: 10.1210/en.2015-1361. Epub 2015 Aug 13.
4
Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells.毒蕈碱受体控制人内分泌L细胞中胰高血糖素样肽1的分泌。
Endocrinology. 2003 Jul;144(7):3244-50. doi: 10.1210/en.2003-0143.
5
Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.Epac参与cAMP刺激的胰高血糖素原表达和激素产生,但不参与胰腺α细胞系和肠L细胞系中的激素分泌。
Am J Physiol Endocrinol Metab. 2009 Jan;296(1):E174-81. doi: 10.1152/ajpendo.90419.2008. Epub 2008 Oct 14.
6
Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies.黄连素对胰高血糖素样肽-1 释放的调节作用:体内和体外研究。
Biochem Pharmacol. 2010 Apr 1;79(7):1000-6. doi: 10.1016/j.bcp.2009.11.017. Epub 2009 Nov 27.
7
Ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in NCI-H716 cells via bile acid receptor activation.人参皂苷代谢物化合物 K 通过激活胆汁酸受体刺激 NCI-H716 细胞分泌胰高血糖素样肽-1。
Arch Pharm Res. 2014;37(9):1193-200. doi: 10.1007/s12272-014-0362-0. Epub 2014 Mar 5.
8
Coregulation of glucagon-like peptide-1 synthesis with proglucagon and prohormone convertase 1 gene expression in enteroendocrine GLUTag cells.肠内分泌GLUTag细胞中胰高血糖素样肽-1合成与胰高血糖素原和激素原转化酶1基因表达的共同调节
Endocrinology. 2001 Jan;142(1):37-42. doi: 10.1210/endo.142.1.7870.
9
Glucocorticoids decrease the production of glucagon-like peptide-1 at the transcriptional level in intestinal L-cells.糖皮质激素在转录水平上降低肠道L细胞中胰高血糖素样肽-1的产生。
Mol Cell Endocrinol. 2015 May 5;406:60-7. doi: 10.1016/j.mce.2015.02.014. Epub 2015 Feb 17.
10
Farnesoid X Receptor (FXR) Interacts with Camp Response Element Binding Protein (CREB) to Modulate Glucagon-Like Peptide-1 (7-36) Amide (GLP-1) Secretion by Intestinal L Cell.法尼酯X受体(FXR)与环磷酸腺苷反应元件结合蛋白(CREB)相互作用,以调节肠道L细胞分泌胰高血糖素样肽-1(7-36)酰胺(GLP-1)。
Cell Physiol Biochem. 2018;47(4):1442-1452. doi: 10.1159/000490836. Epub 2018 Jun 21.

引用本文的文献

1
Intestinal Gastrin/CCKBR Axis Protects against Type 2 Diabetes by Reducing Intestinal Glucose Absorption through the PI3K/Akt/eIF4B Signaling Pathway.肠道胃泌素/缩胆囊素B受体轴通过PI3K/Akt/eIF4B信号通路减少肠道葡萄糖吸收来预防2型糖尿病。
Adv Sci (Weinh). 2025 Apr;12(13):e2410032. doi: 10.1002/advs.202410032. Epub 2025 Feb 14.
2
CCK-1 and CCK-2 receptor agonism do not stimulate GLP-1 and neurotensin secretion in the isolated perfused rat small intestine or GLP-1 and PYY secretion in the rat colon.胆囊收缩素-1 和胆囊收缩素-2 受体激动剂不能刺激离体灌注大鼠小肠中的 GLP-1 和神经降压素分泌,也不能刺激大鼠结肠中的 GLP-1 和 PYY 分泌。
Physiol Rep. 2020 Jan;8(2):e14352. doi: 10.14814/phy2.14352.
3
Clinical factors associated with the occurrence of nausea and vomiting in type 2 diabetes patients treated with glucagon-like peptide-1 receptor agonists.
与接受胰高血糖素样肽-1 受体激动剂治疗的 2 型糖尿病患者恶心和呕吐发生相关的临床因素。
J Diabetes Investig. 2019 Mar;10(2):408-417. doi: 10.1111/jdi.12900. Epub 2018 Aug 22.
4
No Association of Proton Pump Inhibitor Use with Fasting or Postload Glycaemia in Patients with Cardiovascular Disease: A Cross-Sectional Retrospective Study.质子泵抑制剂的使用与心血管疾病患者的禁食或餐后血糖水平无关:一项横断面回顾性研究。
Int J Med Sci. 2017 Sep 2;14(10):1015-1021. doi: 10.7150/ijms.19457. eCollection 2017.
5
Effect of proton pump inhibitors on glycemic control in patients with diabetes.质子泵抑制剂对糖尿病患者血糖控制的影响。
World J Diabetes. 2015 Aug 25;6(10):1122-31. doi: 10.4239/wjd.v6.i10.1122.
6
The gastrin-releasing peptide analog bombesin preserves exocrine and endocrine pancreas morphology and function during parenteral nutrition.胃泌素释放肽类似物蛙皮素在肠外营养期间可维持胰腺外分泌和内分泌形态及功能。
Am J Physiol Gastrointest Liver Physiol. 2015 Sep 15;309(6):G431-42. doi: 10.1152/ajpgi.00072.2015. Epub 2015 Jul 16.